ClinicalTrials.gov record
Recruiting Phase 2 Interventional

A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio

ClinicalTrials.gov ID: NCT07215390

Public ClinicalTrials.gov record NCT07215390. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 12:51 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneration

Study identification

NCT ID
NCT07215390
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Apellis Pharmaceuticals, Inc.
Industry
Enrollment
240 participants

Conditions and interventions

Interventions

  • APL-3007, pegcetacoplan (APL-2) Drug
  • Placebo, Syfovre Other

Drug · Other

Eligibility (public fields only)

Age range
60 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 22, 2025
Primary completion
May 31, 2027
Completion
Oct 31, 2027
Last update posted
Mar 29, 2026

2025 – 2027

United States locations

U.S. sites
43
U.S. states
17
U.S. cities
42
Facility City State ZIP Site status
Barnet Dulaney Perkins Eye Center (01018) Mesa Arizona 85206 Recruiting
Associated Retina Consultants - Phoenix Phoenix Arizona 85020 Recruiting
Retinal Research Institute, LLC (01021) Phoenix Arizona 85053 Recruiting
California Retina Consultants (CRC) - Bakersfield Office Bakersfield California 93309 Recruiting
The Retina Partners - Encino Encino California 07003 Recruiting
Retina Consultants of Orange County - Fullerton Office Fullerton California 93825 Recruiting
Salehi Retina Institute, Inc dba Retina Associate or Southern California (01034) Huntington Beach California 92647 Recruiting
Retina Consultants San Diego Poway California 92064 Recruiting
Orange County Retina Medical Group Santa Ana California 92705 Recruiting
Bay Area Retina Associates - Walnut Creek Walnut Creek California 94598 Recruiting
Colorado Retina Associates, PLLC Lakewood Colorado 80228 Recruiting
Advanced Vision Research Institute Longmont Colorado 80503 Recruiting
Florida Retina Institute - Orlando (01053) Orlando Florida 32806 Recruiting
Retina Specialty Institute - Pensacola Pensacola Florida 32503 Recruiting
Retina Vitreous Associates of Florida (RVA) - Saint Petersburg St. Petersburg Florida 33711 Recruiting
Center for Retina and Macular Disease (01026) Winter Haven Florida 33880 Recruiting
Southeast Retina Center Augusta Georgia 30909 Recruiting
Illinois Retina Associates, S.C. - Oak Park (01061) Oak Park Illinois 60304 Recruiting
Retina Consultants P.C. Indianapolis Indiana 46214 Recruiting
Retina Associates New Orleans - Jefferson Parish Location Metairie Louisiana 70001 Recruiting
Cumberland Valley Retina Consultants (CVRC) Hagerstown Maryland 21740 Recruiting
Mississippi Retina Associates Madison Mississippi 39110 Recruiting
Long Island Vitreoretinal Consultants - Westbury Long Island City New York 11590 Recruiting
Retina Assocaites of Cleveland, Inc (01048) Cleveland Ohio 44122 Recruiting
Verum Research, LLC Eugene Oregon 97401 Recruiting
EyeHealth Northwest Portland Oregon 97225 Recruiting
Mid Atlantic Retina - Philadelphia (01017) Philadelphia Pennsylvania 19107 Recruiting
Charleston Neuroscience Institute LLC - Ladson Ladson South Carolina 29456 Recruiting
Charleston Neuroscience Institute, LLC - Mount Pleasant (01051) Mt. Pleasant South Carolina 29464 Recruiting
Retina Consultants of Texas - Abilene (01035) Abilene Texas 79606 Recruiting
Austin Retina Associates Austin Texas 78705 Recruiting
Retina Consultants of Texas - Bellaire (01067) Bellaire Texas 77401 Recruiting
Texas Retina Associates Dallas Texas 75231 Recruiting
Retina Consultants of Texas - Katy Katy Texas 77494 Recruiting
Valley Retina Institute- McAllen (01076) McAllen Texas 78503 Recruiting
Austin Retina Associates - Round Rock (01032) Round Rock Texas 78681 Recruiting
Retina Consultants of Texas - San Antonio Medical Center San Antonio Texas 78240 Recruiting
Austin Retina Associate (01046) San Marcos Texas 78666 Recruiting
Retina Consultants of Texas (01055) Schertz Texas 78154 Recruiting
Retina Center of Texas - Southlake Southlake Texas 76092 Recruiting
Retina Consultants of Texas - The Woodlands The Woodlands Texas 73384 Recruiting
Tyler Retina Consultants Tyler Texas 75703 Recruiting
University of Wisconsin Health - University Station Clinic Madison Wisconsin 53705 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07215390, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 29, 2026 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07215390 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →